劉崇喜教授

 

JournalPatenBook

 

劉

劉崇喜教授      辦公室:U715    分機:2715

    

學歷:

高雄醫學院,藥學研究所博士班,博士 民國82年6月畢
現職:
大仁科技大學 藥學系 教授,95年7月~迄今 

經歷:
  1. 大仁科技大學 藥學暨健康學院 院長,97年8月~99年7月。
  2. 大仁技術學院中草藥科技研究中心 主任,91年8月~98年7月。
  3. 大仁技術學院 藥學系 系主任,89年2月~91年7月。
  4. 大仁藥專 藥學系 副教授82年7月-95年6月
  5. 大仁藥專 藥學系 講師81年7月~82年6月

Email:

專長:

  1. 中藥炮製學,中藥炮製是根據中醫藥理論,依照辨證施治用藥的需要和藥物自身性質,以及調劑、製劑的不同要求,所採取的一項製藥技術。它為專門研究中藥炮製理論、工藝、規格標準、歷史沿習及其發展方向的學科。
  2. 方劑學,方劑學是在中醫理論指導下研究藥物在臨床治療之技術的科學。本科目講述方劑之方名、組成、使用方法、功用、主治、方解、藥理作用、臨床應用、加減方、辨別方劑等。
 

 

 Journal Papers

 

  1. M.F. Chen, S.S. Liou, T.Y. Hong, S.T. Kao and I.M. Liu *. Gigantol has Protective Effects against High Glucose-Evoked Nephrotoxicity in Mouse Glomerulus Mesangial Cells by Suppressing ROS/MAPK/NF-κB Signaling Pathways. Molecules.2019;24(1)80. (SCI)
  2. W.Y. Liu, S.S. Liou, T.Y. Hong and I.M. Liu *. Hesperidin Prevents High Glucose-Induced Damage of Retinal Pigment Epithelial Cells. Planta medica. 2018;84(12):1030-1037. (SCI)
  3. W.Y. Liu, S.S. Liou, T.Y. Hong and I.M. Liu *. The Benefits of the Citrus Flavonoid Diosmin on Human Retinal Pigment Epithelial Cells under High-Glucose Conditions.  Molecules. 2017;22(12).E2251. (SCI)
  4. W.Y. Liu, S.S. Liou, T.Y. Hong and I.M. Liu *. Protective Effects of Hesperidin (Citrus Flavonone) on High Glucose Induced Oxidative Stress and Apoptosis in a Cellular Model for Diabetic Retinopathy. Nutrients. 2017; 9(12). E1312. (SCI)
  5. T.F. Tzeng, W.Y. Lin,  S.S. Liou, T.Y. Hong and I.M. Liu *. Antioxidant-Rich extract from Plantaginis Seman Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model. Nutrients. 2016,8,572; doi:10.3390/nu8090572. (SCI)
  6. T.F. Tzeng, S.S. Liou, Y.C. Tzeng and I.M. Liu *. Zerumbone, a Phytochenical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats. Nutrients. 2016,8,499; doi:10.3390/nu8080449. (SCI)   
  7. T.Y. Hong, T.F. Tzeng, S.S. Liou, I.M. Liu *. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina. Vascul Pharmacol. 2016;76:18-27.(SCI)
  8. T.F. Tzeng, Y.C. Tzeng, Y.J. Cheng, S.S. Liou, I.M. Liu *. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model. Nutrients. 2015;7(10):8670-8684. (SCI)
  9. T.F. Tzeng, T.Y. Hong, Y.C. Tzeng, S.S. Liou, I.M. Liu *. Consumption of polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes. Nutrients. 2015;7(9):7821-7841. (SCI)
  10. T.F. Tzeng, S.S Liou, C.J. Chang, I.M. Liu*.6-Gingerol dampens hepatic steatosis and inflammation in experimental nonalcoholic steatohepatitis. Phytomedicine. 2015;22:452-461.(SCI)
  11. T.F. Tzeng, S.S Liou, C.J. Chang, I.M. Liu*. 6-Gingerol Protects against Nutritional Steatohepatitis byRegulating Key Genes Related to Inflammation and Lipid Metabolism. Nutrients. 2015; 7(2):999-1020. (SCI)
  12. T.F. Tzeng, S.S. Liou, and I.M. Liu*. 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation and fibrogenesis. RSC advances.2014; 4:61427-61436. (SCI)
  13. H.J. Lu, T.F. Tzeng, S.S. Liou, C.J. Chang, C. Yang, M.C. Wu and I.M. Liu. Ruscogenin ameliorates experimental nonalcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway.BioMed research international.2014;652680. (SCI)
  14. H.J. LU, S.S. Liou, C.J. Chang, S.D. Lin, C. Yang, M.C. Wu, I.M. Liu. Ruscogenin protects against high-fat diet-induced nonalcoholic steatohepatitis in hamsters. Planta Medica.2014;80:870-879. (SCI)
  15. T.F. Tzeng, H.J. Lu, S.S. Liou, C.J. Chang, I.M. Liu*. Lipid-lowering effects of zerumbone, a natural cyclic sesquiterpene of Zingiber zerumbet Smith, in high-fat diet-induced hyperlipidemic hamsters. Food and chemical toxicology.2014;69:132-139. (SCI)
  16. H.J. Lu, T.F. Tzeng, S.S. Liou, S.D. Lin, M.C. Wu* and I.M. Liu*. Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways. BMC complementary and alternative medicine.2014;14:156. (SCI)
  17. C.J. Chang, S.S. Liou, T.F. Tzeng, I.M. Liu*.The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet. Food and chemical toxicology.2014;65:33-42. (SCI)
  18. H.J. Lu, T.F. Tzeng, S.S. Liou, S.D. Lin, M.C. Wu* and I.M. Liu*. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.BMC complementary and alternative medicine.2014;14:110. (SCI)
  19. T.F. Tzeng, S.S. Liou, C.J. Chang, I.M. Liu*.The ethanol extract of Lonicera japonica (Japanese honeysuckle) attenuates diabetic nephropathy by inhibiting p-38 MAPK activity in streptozotocin-induced diabetic rats. Planta Medica.2014;80:121-129. (SCI)
  20. T.F. Tzeng, S.S. Liou, C.J. Chang and I.M. Liu*. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephrobpathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutrition & Metabolism.2013;10:64. (SCI)
  21. T.F. Tzeng, S.S. Liou, C.J. Chang and I.M. Liu. Zerumbone, a natural cyclic sesquiterpene of Zingiber zerumbet smith, attenuates nonalcoholic fatty liver disease in hamsters fed on high-fat diet. Evidence-based complementary and alternative medicine. 2013; 2013:303061,9pages doi: 10.1155
  22. /2013/303061. (SCI)
  23. F. Tzeng, S.S. Liou, I.M. Liu. The selected traditional chinese medicinal formulas for treating diabetic nephropathy:perspective of modern science. Journal of Traditional and Complementary Medicine.2013;3(3):152-158.
  24. T.F. Tzeng, S.S. Liou, C.J. Chang and I.M. Liu. The ethanol extract of Zingiber zerumbet attenuates streptozotocin-induced diabetic nephropathy in rats. Evidence-based complementary and alternative medicine. 2013:340645. doi: 10.1155/2013/340645. (SCI)

 

 

 TOP

 

Patent

  1. 劉崇喜;劉怡旻;陳威丞,『牛樟芝圓粒結構』,大陸實用新型專利,已核准證書字號:2628188,2012.6.28~2022.06.27。
  2. 劉崇喜;劉怡旻;李瑞瑜,『從山藥塊根外皮萃取抗氧化物質之製備方法』,中華民國發明專利,已核准證書字號:I379687,2012.12.21 ~ 2029.9.8。
  3. 劉崇喜;劉怡旻;陳威丞,『封閉式牛樟芝物流管控裝置』,中華民國新型專利,已核准證書字號:M443892,2012.12.21~2022.6.25。
  4. 劉崇喜;劉怡旻;黃郁婷,『抑制腫瘤的藥用真菌藥錠結構』,大陸實用新型專利,已核准證書字號:2544155,2011.12.9~2021.12.8。
  5. 劉崇喜;劉怡旻;陳威丞,『具有光照單元的牛樟芝培養箱』,大陸實用新型專利,已核准證書字號:2449463,2012.3.1~2022.2.31。
  6. 劉崇喜;劉怡旻;陳威丞,『牛樟芝物流管控裝置』,大陸實用新型專利,已核准證書字號:2448387,2012.1.20~2022.1.19。
  7. 劉崇喜;劉怡旻;陳威丞,『具有光照單元的牛樟芝培養箱』,中華民國新型專利,已核准證書字號:M433086,2012.7.11~2022.2.22。
  8. 劉崇喜;劉怡旻;陳威丞,『牛樟芝培養箱』,大陸實用新型專利,已核准證書字號:2239177,2011.9.29~2021.9.28。
  9. 劉崇喜;劉怡旻;陳威丞,『牛樟芝物流管控裝置』,中華民國新型專利,已核准證書字號:M429146,2012.5.11~2022.1.12。
  10. 劉怡旻;劉崇喜;張家茹,『薄荷抗氧化物質之恆溫萃取法』,中華民國發明專利,已核准證書字號:I361097,2012.4.1~2029.8.30。
  11. 劉崇喜;劉怡旻;黃郁婷,『具抑制腫瘤之藥用真菌藥錠結構』,中華民國新型專利,已核准證書字號:M425668,2012.4.1~2021.11.28。
  12. 劉崇喜;劉怡旻;陳威丞,『牛樟芝培養箱』,中華民國新型專利,已核准證書字號:M421698,2012.2.1~2021.9.22。
  13. 王伯綸;劉崇喜,劉怡旻;張家茹,『微膠囊』,大陸實用新型專利,已核准證書字號:1925283,2011.1.26~2021.1.25。
  14. 劉崇喜;劉怡旻;黃郁婷;張家茹,『四物滴丸』,中華民國新型專利,已核准證書字號:M408367,2011.8.1~2021.1.24。
  15. 劉崇喜;劉怡旻;黃郁婷;張家茹,『四物滴丸』,大陸實用新型專利,已核准證書字號:2300506,2011.7.15~2021.7.14。
  16. 王伯綸;劉崇喜,劉怡旻;張家茹,『當歸微膠囊』,中華民國新型專利,已核准證書字號:M404712,2011.6.1~2020.12.16。
  17. 劉崇喜;劉怡旻,『中藥當歸之定量定溫及定時炮製法』,中華民國發明專利,已核准證書字號:I339123,2011.3.21~2027.9.6。
  18. 劉崇喜;劉怡旻;張家茹;唐偉智,『一種預防或治療貧血之中草藥 複方萃取物.其製備方法及其醫藥組合物』,美國發明專利,已核准證書字號:US8,420,136 B2。
 

 TOP

Book

  1. 劉崇喜,『方劑學』,泓京出版社,2010.1
 

 TOP